Pre-IPO Jenscare Scientific - Difficult to Achieve Expected Commercialization Results
Jenscare’s products have to face fierce competition, with slow development progress. The severe shortage of doctors and limited qualified hospitals...
295 Views
Pre-IPO OrbusNeich Medical Group - The Industry, the Business and the Concerns
The rich pipeline and large global business will help OrbusNeich “hedge” negative domestic policy impact. But fierce competition, slow progress in...
472 Views
Pre-IPO Shanghai NewMed Medical - Concerns on Fierce Competition and Future Commercialization
We analyzed the industry characteristics of heart valve device market. Concerns of NewMed are mainly the slow product development progress, fierce...
268 Views
ECM Weekly (29th August 2021) - Imeik, Helen’s, Jenscare, Dingdang, Simplex, Hyundai Heavy
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
277 Views
Jenscare (宁波健世科技) Pre-IPO: Differentiated Heart Valve Portfolio
Jenscare has a differentiated heart valve portfolio with leadership in the tricuspid heart valve replacement segment. We think the company is...
271 Views